by Clinical Neuropsychologist Online | Tuesday, September 15, 2026 | Dementia
Abstract INTRODUCTION We studied dementia incidence and risk factors in Indigenous Tsimane and Moseten Amerindian populations in Amazonian Bolivia with largely subsistence lifestyles. METHODS A median of 4.7 years after baseline dementia assessment, 730 participants...
by Clinical Neuropsychologist Online | Tuesday, September 15, 2026 | Dementia
Abstract INTRODUCTION Lysosomal dysfunction contributes to Alzheimer’s disease (AD) by impairing protein clearance and promoting neuroinflammation. Cathepsin H (CTSH), a lysosomal protease, recently emerged as a protective AD locus. We investigated how CTSH is...
by Clinical Neuropsychologist Online | Tuesday, September 15, 2026 | Dementia
Abstract INTRODUCTION Amyloid positivity does not reliably predict near-term cognitive decline in preclinical Alzheimer’s disease (AD). We tested whether digital cognitive phenotyping improves prognostic precision. METHODS Baseline performance on a brief...
by Clinical Neuropsychologist Online | Tuesday, September 15, 2026 | Neuropsychology (general)
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 15, 2026 Neuro-General Previous Page
by Clinical Neuropsychologist Online | Tuesday, September 15, 2026 | Neuro Podcasts
Today we have part 2 of our report writing pearls of wisdom episode. Part 1 was released a couple months ago (episode #195). Other episodes in this clinical insights series include #175 on the clinical interview and #183 on testing. Show notes are available at...
